Skip to main content

Minocycline topical Pregnancy and Breastfeeding Warnings

Medically reviewed by Last updated on May 23, 2022.

Minocycline topical is also known as: Amzeeq, Arestin, Cleeravue-M, Zilxi

Minocycline topical Pregnancy Warnings

Minocycline topical powder has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of embryo and fetotoxicity. There are no controlled data in human pregnancy. However, there have been reports of congenital defects associated with the tetracycline class of antibiotics. Minocycline topical should only be given during pregnancy when benefit outweighs risk.

See references

Minocycline topical Breastfeeding Warnings

Minocycline is excreted into human milk. Theoretical risks of dental staining and inhibition of bone growth exist but are unlikely. Tetracycline, a related drug, is considered compatible with breast-feeding by the American Academy of Pediatrics.

See references

References for pregnancy information

  1. "Product Information. Minocin (minocycline)." Lederle Laboratories (2002):
  2. "Product Information. Arestin (minocycline topical)." OraPharma Inc (2001):

References for breastfeeding information

  1. "Product Information. Arestin (minocycline topical)." OraPharma Inc (2001):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.